PMS35 The Cost-Effectiveness of Pegloticase in the Treatment of Refractory Chronic Gout
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.224
https://www.valueinhealthjournal.com/article/S1098-3015(12)00289-6/fulltext
Section Title :
Muscular-Skeletal Disorders
Section Order :
993
First Page :
A39
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00289-6&doi=10.1016/j.jval.2012.03.224